The Expression of Autophagy Markers Beclin1 and LC3B in Prostatic Carcinoma: Immunohistochemical Case-Control Study
Background and Objective: Prostatic carcinoma represents the second most common cancer diagnosed in men worldwide after lung cancer and the fourth common male malignancy in Egypt. Autophagy is a natural process that has both oncogenic and tumor-suppressive activities. This study aims to evaluate the...
Saved in:
Main Authors: | Nanis Holah (Author), Marwa Serag El-Dien (Author), Shereen Mahmoud (Author) |
---|---|
Format: | Book |
Published: |
Iranian Society of Pathology,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role for autophagy-related markers Beclin-1 and LC3 in endometriosis
by: Zhiwei Kong, et al.
Published: (2022) -
Evaluation of the expression of LC3-II and BECLIN1 genes of autophagy pathway in patients with hematological malignancies
by: Hossein Ayatollahi, et al.
Published: (2023) -
Effects of an orally supplemented probiotic on the autophagy protein LC3 and Beclin1 in placentas undergoing spontaneous delivery during normal pregnancy
by: Ping Yang, et al.
Published: (2020) -
Diagnostic utility of immunohistochemical marker prostein for evaluation of primary and metastatic prostatic carcinomas
by: Gowri Garudadri, et al.
Published: (2020) -
Expression of the autophagic markers, light chain 3-I, light chain 3-II, and beclin 1, in vitiligo: a case-control study
by: Ghada M El-Hanafy, et al.
Published: (2021)